✦ LIBER ✦

LY354740, a group II metabotropic glutamate receptor agonist with potential antiparkinsonian properties in rats

✍ Scribed by J. Konieczny; K. Ossowska; S. Wolfarth; A. Pilc

Publisher: Springer-Verlag
Year: 1998
Tongue: English
Weight: 75 KB
Volume: 358
Category: Article
ISSN: 0028-1298
DOI: 10.1007/pl00005284

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Anxiolytic effects of a novel group II m

Anxiolytic effects of a novel group II metabotropic glutamate receptor agonist (LY354740) in the fear-potentiated startle paradigm in humans

✍ Christian Grillon; Jeremy Cordova; Louise R. Levine; Charles A. Morgan, III 📂 Article 📅 2003 🏛 Springer 🌐 English ⚖ 231 KB

Stereocontrolled Synthesis of a Potent A

Stereocontrolled Synthesis of a Potent Agonist of Group II Metabotropic Glutamate Receptors, (+)-LY354740, and Its Related Derivatives.

✍ Yasufumi Ohfune; Takashi Demura; Seiji Iwama; Hiromi Matsuda; Kosuke Namba; Keik 📂 Article 📅 2003 🏛 John Wiley and Sons ⚖ 72 KB 👁 2 views

Stereocontrolled synthesis of a potent a

Stereocontrolled synthesis of a potent agonist of group II metabotropic glutamate receptors, (+)-LY354740, and its related derivatives

✍ Yasufumi Ohfune; Takashi Demura; Seiji Iwama; Hiromi Matsuda; Kosuke Namba; Keik 📂 Article 📅 2003 🏛 Elsevier Science 🌐 French ⚖ 258 KB

Efficient synthesis of (+)-2-aminobicyclo[3.1.0]hexane-2,6-dicarboxylic acid (LY354740: 1) and its structurally related analogs (-)-2 and (-)-3 has been accomplished starting with (1S,2R)-1-amino-2-hydroxycyclopentane-or cyclohexanecarboxylic acid (4 or 17 ) via an intramolecular cyclopropanation of

The group II metabotropic glutamate rece

The group II metabotropic glutamate receptor agonist, LY379268, inhibits both cocaine- and food-seeking behavior in rats

✍ Jamie Peters; Peter W. Kalivas 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 283 KB

Potent, stereoselective, and brain regio

Potent, stereoselective, and brain region selective modulation of second messengers in the rat brain by (+)LY354740, a novel group II metabotropic glutamate receptor agonist

✍ D. D. Schoepp; Bryan G. Johnson; Rebecca A. Wright; Craig R. Salhoff; James A. M 📂 Article 📅 1998 🏛 Springer-Verlag 🌐 English ⚖ 102 KB

Preliminary evidence of attenuation of t

Preliminary evidence of attenuation of the disruptive effects of the NMDA glutamate receptor antagonist, ketamine, on working memory by pretreatment with the group II metabotropic glutamate receptor agonist, LY354740, in healthy human subjects

✍ John H. Krystal; Walid Abi-Saab; Edward Perry; D. Cyril D’Souza; Nianjin Liu; Ra 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 155 KB